Hu Lei

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Cancer Stem Cells

Radical Prostatectomy

Top Venues

Leukemia & lymphoma

Biomarker research

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Jiaqi Wang, Jiacheng Hu, Qian Zhu, Yingli Wu
Deubiquitinases in hematological malignancies. Biomarker research 9 (1) (2021)
Yang Cao, Huizhuang Shan, Meng Liu, Jia Liu, Zilu Zhang, Xiaoguang Xu, Yue Liu, Hanzhang Xu, Hu Lei, Miao Yu, Xingming Zhang, Wanting Liu, Zhilei Bu, Zhixiao Fang, Yanjie Ji, Hua Yan, Weiying Gu, Ying-Li Wu
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib. Cell death & disease 12 (4) (2021)
Hu Lei, Han-Zhang Xu, Hui-Zhuang Shan, Meng Liu, Ying Lu, Zhi-Xiao Fang, Jin Jin, Bo Jing, Xin-Hua Xiao, Shen-Meng Gao, Feng-Hou Gao, Li Xia, Li Yang, Li-Gen Liu, Wei-Wei Wang, Chuan-Xu Liu, Yin Tong, Yun-Zhao Wu, Jun-Ke Zheng, Guo-Qiang Chen, Li Zhou, Ying-Li Wu
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. Nature communications 12 (1) (2021)
Huizhuang Shan, Yang Cao, Xinhua Xiao, Meng Liu, Yunzhao Wu, Qi Zhu, Hanzhang Xu, Hu Lei, Zhu-Jun Yao, Ying-Li Wu
YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma. Signal transduction and targeted therapy 5 (1) (2020)
Caixia Tang, Hu Lei, Jinfu Zhang, Meng Liu, Jin Jin, Hao Luo, Hanzhang Xu, Yingli Wu
Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells. Cancer biology & therapy 19 (8) (2018)
Hu Lei, Weiwei Wang, Yingli Wu
Targeting oncoproteins for degradation by small molecules in myeloid leukemia. Leukemia & lymphoma 59 (10) (2017)
Hu Lei, Huizhuang Shan, Yingli Wu
Targeting deubiquitinating enzymes in cancer stem cells. Cancer cell international 17 (2017)